ストックスクリーナーアプリを入手
49.73
0.85%
0.42
前日終値:
$49.31
開ける：
$49.22
24時間の取引高:
3,494
Relative Volume:
0.06
時価総額：
$229.97M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+2.07%
1か月 パフォーマンス:
+3.73%
6か月 パフォーマンス:
+20.67%
1年 パフォーマンス:
+8.11%
1日の値動き範囲:
$49.22
$49.89
1週間の範囲:
$48.29
$49.89
52週間の値動き範囲:
$35.22
$49.89
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
XPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
49.77 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.62 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.90 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
686.26 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.28 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
631.56 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf (XPH) 最新ニュース
P Pharmaceuticals ETF stock responds to job market shiftsWeekly Trade Analysis & Fast Moving Stock Trade Plans - newser.com
Aug Analyst Calls: P Pharmaceuticals ETF stock enhance shareholder valueMarket Movers & Daily Chart Pattern Signals - nchmf.gov.vn
P Pharmaceuticals ETF stock enhance shareholder value2025 Earnings Impact & Real-Time Volume Surge Alerts - newser.com
P Pharmaceuticals ETF stock prepared for digital transition2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
P Pharmaceuticals ETF stock overpriced at current multiples2025 Retail Activity & Daily Chart Pattern Signal Reports - Trung tâm Dự báo KTTV quốc gia
P Pharmaceuticals ETF stock return to pre crash levelsProduct Launch & Daily Risk Controlled Trade Plans - Trung tâm Dự báo KTTV quốc gia
SPDR Series TrustSPDR S&P Pharmaceuticals ETF (SSGE.HM) latest stock news and headlines - Yahoo
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView
XPH: Small-Cap Pharma Turns Higher, At Long Last (NYSEARCA:XPH) - Seeking Alpha
Seeking Alpha's healthcare quant picks ahead of Q3 earnings: McKesson, Incyte top-rated stocks - MSN
Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock - MSN
P Pharmaceuticals ETF stock beat international competitionJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
SPDR Pharmaceuticals ETF Index (^KZP) options chain - Yahoo
P Pharmaceuticals ETF stock protected from inflationJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag - MSN
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman - Seeking Alpha
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
6 Best Health Care Funds and ETFs for 2025 - US News Money
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - inkl
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - TradingView
SPDR S&P Biotech ETF (XBI) Top 25 Holdings - TIKR.com
SPDR S&P Pharmaceuticals ETF $XPH Stake Boosted by Goldman Sachs Group Inc. - Defense World
Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock - Seeking Alpha
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
The Best Health Care ETFs to Buy - Kiplinger
XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? (NYSEARCA:XLV) - Seeking Alpha
Simplex Trading LLC Buys Shares of 627 SPDR S&P Pharmaceuticals ETF $XPH - Defense World
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. - inkl
Spdr Pharmaceuticals Etf (XPH) 財務データ
Spdr Pharmaceuticals Etf (XPH) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.03%
0.86%
大文字化:
|
ボリューム (24 時間):